Table 2 Characteristics of the 28 G-POEM procedures performed with LED probe
From: Feasibility of using an led-probe in third-space endoscopy: a clinical study
Patients N = 28 | Value | |||
|---|---|---|---|---|
Age, mean (SD), years | 43.7 ± 10.1 | |||
Sex, male, n (%) | 13 (46.4) | |||
Etiology, n (%) | ||||
• Diabetic | 12 (42.9%) | |||
• Idiopathic | 11 (39.2%) | |||
• Postsurgical | 5 (17.9%) | |||
Duration of disease before G-POEM, mean (SD), months | 22.2 ± 5.5 | |||
Predominant symptoms, n (%) | ||||
• Nausea/vomiting | 15 (53.5%) | |||
• Abdominal pain | 8 (28.6%) | |||
• Gastric fullness | 5 (17.9%) | |||
Previous therapy, n (%) | ||||
• Medical treatment | 22 (78.7%) | |||
• Botulinum toxin injection | 5 (17.8%) | |||
• Transpyloric stenting | 1 (3.5%) | |||
Procedure | ||||
Tunnel length, mean (SD), cm | 5.2 ± 0.96 | |||
Myotomy length, mean (SD), cm | 3.2 ± 0.82 | |||
LP placement time, median (IQR), min | 6 (5-7) | |||
Patients with inadequate submucosal tunnel direction after initial classic G-POEM procedure that benefited from LP use, n (%) | 5 (17.8%) | |||
Total G-POEM time, median (IQR), min | 60 (48–77) | |||
Adverse Events, n (%) | 4 (14.2%) | |||
• Capnoperitoneum | 2 (7.1%) | |||
• Mucosal tear | 1 (3.5%) | |||
• Prepyloric ulcer | 1 (3.5%) | |||
G-POEM outcomes | PRE-GPOEM | POST-GPOEM 3 m | POST-GPOEM 6 m | Pvalue |
GSCI score, mean (SD), points | 3.5 ± 0.64 | 1.8 ± 0.61 | 1.2 ± 0.43 | < 0.0011 |
RP4H, mean (SD), percentage | 35.3 ± 11.6 | 11.1 ± 4.2 | 9.3 ± 3.2 | < 0.0011 |
MHET, mean (SD), minutes | 260.2 ± 66.9 | 165.9 ± 31.2 | 152.7 ± 23.1 | < 0.0011 |